Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. ESC Action Center

Effects of empaglifozin on kidney outcomes after acute MI

Deepak Bhatt at ESC
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    ESC 2024 - Deepak Bhatt gives an overview of the kidney results from the EMPACT-MI trial among patients with acute MI. “What we found in fact was quite reassuring, there was no excess of adverse kidney events with empagliflozin versus placebo”, says Deepak Bhatt.

  • Educational information

    This video was recorded during the ESC Congress 2024 in London, UK.

  • Faculty

    Deepak Bhatt, MD is Director of Mount Sinai Heart, New York, NY, US. He also serves as the first-ever Dr. Valentin Fuster Professor of Cardiovascular Medicine.

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Release date: 11 September 2024

Recommended
Details
Presenters
Comments
  • Overview

    ESC 2024 - Deepak Bhatt gives an overview of the kidney results from the EMPACT-MI trial among patients with acute MI. “What we found in fact was quite reassuring, there was no excess of adverse kidney events with empagliflozin versus placebo”, says Deepak Bhatt.

  • Educational information

    This video was recorded during the ESC Congress 2024 in London, UK.

  • Faculty

    Deepak Bhatt, MD is Director of Mount Sinai Heart, New York, NY, US. He also serves as the first-ever Dr. Valentin Fuster Professor of Cardiovascular Medicine.

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Release date: 11 September 2024

Schedule14 Oct 2024